Know Your Breast Cancer 2017-05-16T15:28:01+00:00
Agendia Building

What is Genomic Testing?

Genomic tests are not the same as genetic tests. Genomic testing looks at the specific genes in a tumor to find out what is driving its growth. Genetic tests determine your inherited risk or hereditary predisposition for cancer. Early-stage breast cancer patients benefit from MammaPrint genomic testing to learn about recurrence rate and treatment options.

GENOMIC VS GENETIC >>
MAMMAPRINT GENOMIC TESTING >>

 

MammaPrint® has the Answer.

The majority of women with early-stage breast cancer have a Low Risk of cancer relapse and may safely avoid chemotherapy.1 So how do you know if chemotherapy will benefit you? The MammaPrint® 70-Gene Assay is the only FDA-cleared risk of recurrence test that provides a personalized, definitive result so you can know with certainty if you are at Low Risk for cancer relapse – and not likely to benefit from chemotherapy.

1. Cardoso F, van’t Veer LJ, Bogaerts J et al. 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer. N Engl J Med. 2016; 375:717-29.

LOCATE A PHYSICIAN >>

 

MammaPrint: The clarity you need when it matters most.

You have just been diagnosed with cancer and it is a difficult time for you and your loved ones. You want control of the situation, clarity in your options and confidence in the treatment decision you make.

This video describes the path of three patients after their diagnosis and how MammaPrint helps guide them and their physician with their treatment plan.
LEARN MORE ABOUT MAMMAPRINT >>

Join the Symphony Sisterhood.

Tens of thousands of breast cancer
patients are part of our community.

Visit our Facebook page today.

sisterhood